Skip to main content
Official record dossierRemedySettlement

FTC announces proposed consent agreement with Express Scripts

The FTC announced a proposed consent agreement with Express Scripts and affiliated entities addressing formulary design, patient cost sharing, manufacturer compensation, plan-sponsor transparency, community-pharmacy reimbursement, and related business practices.

Records announced remedy terms in the pending administrative matter. The filing does not establish realized savings, changes in PBM market structure, or a basis for calculating the withheld market HHI.

  • Record identityevt-pbm-express-scripts-settlement-2026Feb 4, 2026
  • Official scopeSettlementFederal Trade Commission
  • Market scope1 linked contextSeparately bounded profiles
  • Permitted inferenceChronology + contextNo automatic causal claim

Exact named-organization edges

Who this official record names

2 encoded relationships

Remedy subject

Ascent Health Services, LLC

Group purchasing organization named in the FTC insulin administrative complaint record.

Source-specific evidence

The FTC settlement announcement identifies affiliated group purchasing organization Ascent Health Services among the entities subject to the proposed consent agreement.

Remedy subject

Express Scripts, Inc.

Pharmacy benefit manager named in FTC study and administrative complaint records.

Source-specific evidence

The FTC settlement announcement identifies Express Scripts among the entities subject to the proposed consent agreement.

A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.

Descriptive economic context

Public HHI evidence around this date

Each row searches one linked market profile for strict pre-event, same-year, and strict post-event observations. Missing anchors remain part of the result.

0Paired
0One-sided
1Unavailable
HHI unavailablePBMs

United States / Health care

Strict pre
Unavailable
No earlier HHI
Event year
Unavailable
No same-year HHI
Strict post
Unavailable
No later HHI
Pre-post change
Not available
Pair not available

Before/after HHI differences are descriptive comparisons between discrete public releases. They do not estimate the causal effect of the policy event.

Bounded market context

Markets linked to this record

1 profile handoff

United States / Health care

HHI unavailable

PBMs

Pharmacy benefit management services profile based on FTC public findings. The FTC reports top-three and top-six aggregate shares but not enough individual PBM market shares in the public press-release record to compute HHI.

Open market profile

A linked market identifies the observatory context assigned to this record. It is not necessarily the relevant antitrust market alleged or adjudicated in the official matter.

Source custody

Official source behind the record

Source ID ftc-express-scripts-settlement-2026

Federal Trade Commission / agency report

FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients

FTC announcement and proposed consent-order record resolving the administrative action against Express Scripts and affiliated entities.

Accessed Jul 20, 2026. Federal Trade Commission, FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients, February 4 2026.

License note: Public federal government record

Nearby observatory chronology

Other records sharing these market contexts

3 related by market link

Explicit proceeding membership / record 2 of 3

FTC insulin-rebate administrative matter

Open the declared chronology before using market-linked nearby records as broader context.

Proceeding dossier

This chronology is generated from shared observatory market links. It does not assert that the records concern the same matter, conduct, parties, or theory of harm.

Reproducible record packet

Reuse this record and its joins

Filtered routes preserve the exact event ID across the official record, named-organization edges, descriptive market windows, and linked market profiles.

Event ID
evt-pbm-express-scripts-settlement-2026
Profile slug
pbm-express-scripts-settlement-2026
Docket
Docket No. 9437
License
CC BY 4.0

Official-record interpretation boundary

A record dossier preserves what one dated official source says and the observatory context linked to it. It does not convert allegations into findings, findings into economy-wide conclusions, or nearby market indicators into causal effects.

A linked market identifies the observatory context assigned to this record. It is not necessarily the relevant antitrust market alleged or adjudicated in the official matter.

Evidence standard